Therefore, it is plausible that defective handling of invasive AIEC strains in patients with IBD who have genetic mutations linked to defects in microbial processing contributes to intestinal injury, as suggested by increased response of monocytes from Crohn disease patients with NOD2 mutations to AIEC infection in vitro [45]. The gene discussed is NOD2; the disease is Crohn disease.